B & T CAPITAL MANAGEMENT DBA ALPHA CAPITAL MANAGEMENT – CRISPR Therapeutics AG Transaction History
B & T CAPITAL MANAGEMENT DBA ALPHA CAPITAL MANAGEMENT portfolio value:
$1.96M
portfolio value
B & T CAPITAL MANAGEMENT DBA ALPHA CAPITAL MANAGEMENT quarter portfolio value change:
+7.54%
quarter
CRISPR Therapeutics AG 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +11.94% | 3.21K shares | 333K | $65.35 | 30.11K |
| Q2 2022 | share | Increase | +15.35% | 3.58K shares | 171K | $60.77 | 26.90K |
| Q1 2022 | share | Increase | +3.79% | 852 shares | -239K | $62.77 | 23.32K |
| Q4 2021 | share | Decrease | -9.72% | -2.41K shares | -1.08M | $78.85 | 22.47K |
| Q3 2021 | share | Decrease | -2.23% | -569 shares | -1.33M | $111.93 | 24.89K |
| Q2 2021 | share | Increase | +205.20% | 17.11K shares | 3.10M | $161.89 | 25.46K |
| Q1 2021 | share | Increase | +61.10% | 3.16K shares | 223K | $121.85 | 8.34K |
| Q4 2020 | share | Increase | 0.00% | 5.17K shares | 793K | $153.11 | 5.17K |